FemiLift®

The procedure is virtually painless and requires no anesthesia. Many patients feel and see improvement after the first treatment, although the procedure calls for three treatments each spaced four weeks apart for optimal results. You can return to normal activities right after the procedure, but should refrain from sexual activity for five days.

For decades our only option for managing urogenital symptoms of menopause including vaginal dryness, painful intercourse, and urinary symptoms was the use of vaginal estrogen therapy. For many women (20%), hormone therapy fails to relieve urogenital symptoms. Additionally, there are some women who prefer to avoid the risks associated with hormone use or cannot use hormones because of breast cancer history. FemiLift® Vaginal Rejuvenation in Cincinnati is a revolutionary treatment for urogenital symptoms attributed to low estrogenic states or menopause without the use of hormones.

After childbirth, many women experience a change in their vagina which can lead to urinary incontinence and decreased sensation during sex. Similarly, with menopause there are changes that can occur to the vaginal tissue; vaginal dryness is a primary concern for many peri-menopausal and post-menopausal women. Also, lichen sclerosus is a chronic debilitating disease of the vulva.

Patients report immediate changes; even after one treatment session. The full benefits of the FemiLift® treatments are enjoyed 30 days after the third treatment session. The results are best maintained with yearly or semi-annual maintenance treatments.

The internal vaginal FemiLift® treatment is pain-free. You will feel pressure from the probe similar to a pelvic exam. The external Co2 that is mainly used for lichen sclerosus is moderately uncomfortable. We have developed a protocol at Amy Brenner, MD & Associates with topical numbing cream and the ProNox® (inhaled nitrous oxide) to help keep you as comfortable as possible.

We will ask you to abstain from intercourse, hot tubs, and pools for 72 hours following treatment.

In general, FemiLift® offers a safe and effective non-surgical vaginal rejuvenation with a highly unlikely chance of having an adverse effect. Theoretically, since laser energy is used to heat the tissue, the following have been reported in the medical literature: skin burns, scarring, pain. Thus, it is important to go to a qualified physician or provider with experience in sexual medicine, lasers, and aesthetics.

FemiLift® is not for everyone. Anyone with an active infection should wait until the infection resolves. Patients with significant atrophy, scarring or narrowing of the vaginal canal due to atrophy or lichen sclerosus may not be able to insert the laser wand.

Other non-candidates include: Women with a significant pelvic floor vaginal laxity involving significant widening and muscular separation; these women need a surgical repair and will be disappointed with a laser procedure. Women with significant urinary incontinence and/or prolapse; these women need a surgical repair / “sling” or “tape” procedure. Women who have never had an orgasm who are hoping this is the “magic bullet.” Women who have dyspareunia or painful intercourse (not due to atrophy). These women would be better suited to have the O-shot® alone or other gynecologic evaluation and treatment. Women with severe atrophy that would not be able to tolerate the laser probe insertion.

However, women with significant symptoms may want to combine FemiLift® with O-Shot®, WAVE therapy and/or bioidentical hormones for enhanced results. Consulting with one of our providers is the first step to determining which procedures or surgeries are a right fit for you.